Re: CKD Reata / Market Cap
|
8
|
Resverlogix Corp.
|
May 04, 2019 11:31AM
|
Another country listed on EU Clinical Trial Register for BETonMACE
|
8
|
Resverlogix Corp.
|
Dec 09, 2015 12:47PM
|
BETonMACE Enrollment
|
7
|
Resverlogix Corp.
|
Mar 21, 2017 04:22PM
|
Re: Congratulations To.....
|
7
|
Resverlogix Corp.
|
Dec 11, 2019 07:18AM
|
Re: Apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation
|
7
|
Resverlogix Corp.
|
Jun 07, 2018 10:50AM
|
Resverlogix tweet regarding apabetalone/CKD
|
7
|
Resverlogix Corp.
|
May 16, 2017 10:49PM
|
Re: BioSpace-Amgen's Repatha
|
7
|
Resverlogix Corp.
|
Nov 15, 2017 11:13PM
|
Re: Posters out
|
7
|
Resverlogix Corp.
|
May 14, 2019 04:59PM
|
Re: eGFR and Cognition?
|
7
|
Resverlogix Corp.
|
Nov 22, 2019 05:21PM
|
Re: A "toning down" of todays NR..re: inflammation
|
7
|
Resverlogix Corp.
|
Aug 29, 2017 05:14PM
|
Re: More Than Just DSMB Green Light
|
7
|
Resverlogix Corp.
|
Nov 01, 2017 01:18PM
|
FXR and liver transaminase related adverse events
|
7
|
Resverlogix Corp.
|
Sep 18, 2018 11:25PM
|
Re: Is It Possible That
|
7
|
Resverlogix Corp.
|
Nov 01, 2017 01:33PM
|
Re: And volume shoots up again...281K traded
|
7
|
Resverlogix Corp.
|
Dec 09, 2019 02:28PM
|
Re: One point I want to make clear...
|
7
|
Resverlogix Corp.
|
Feb 14, 2019 09:46PM
|
Re: Explanation of difference between Endcrinology and CVD
|
7
|
Resverlogix Corp.
|
Oct 05, 2015 10:41AM
|
Re: Anacetrapib Officially Bites the Dust
|
7
|
Resverlogix Corp.
|
Oct 12, 2017 10:35AM
|
Re: Seeming lack of interest
|
7
|
Resverlogix Corp.
|
Sep 12, 2019 09:44AM
|
Q4 Events page updated
|
7
|
Resverlogix Corp.
|
Oct 11, 2016 03:29PM
|
Re: Take Home Points: not ready for use in patients
|
7
|
Resverlogix Corp.
|
Nov 16, 2019 04:29PM
|